Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function - A single-center experience

Clinical Transplantation

Volumn 23, Issue 5, 2009, Pages 606-615

  Siekierka Harreis, Magdalena ^a   Kuhr, Nicola ^a   Willers, Rainhart ^a   Ivens, Katrin ^a   Grabensee, B ^a   Mondry, Adrian ^b   Loh, Marie C S ^c   Rump, Lars Christian ^a   Blume, Cornelia ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c BIOINFORMATICS INSTITUTE   (Singapore)

Author keywords

Angiotensin II type receptor gene A1166C polymorphism; Angiotensin converting enzyme gene I D polymorphism; Angiotensinogen gene M235T polymorphism; Clinical study; K nearest neighbor; Pattern recognition; Risk factors; Transplant function loss

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENAL GRAFT DYSFUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GRAFT REJECTION; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350158809     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01033.x     Document Type: Article

References (38)

1. Kasiske BL, Vazquez MA, Harmon WE. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000, 11(Suppl 15):S1.
2. Rump LC, Oberhauser V, Schwertfeger E. Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients. J Hypertens 2000, 18:1115.
3. Kasiske BL, Anjum S, Shah R. Hypertension after kidney transplantation. Am J Kidney Dis 2004, 43:1071.
4. Opelz G, Dohler B. Improved long-term outcome after renal transplantation associated with blood pressure control. Am J Transplant 2005, 5:2725.
5. Bantis C, Ivens K, Kreusser W. Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy. Am J Nephrol 2004, 24:258.
6. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343.
7. Mizuiri S, Yoshikawa H, Tanegashima M. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy. Am J Kidney Dis 1998, 31:301.
8. Danser AH, Schalekamp MA, Bax WA. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387.
9. Staessen JA, Wang JG, Ginocchio G. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997, 15:1579.
10. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996, 94:708.
11. Abdi R, Tran TB, Zee R, Brenner BM, Milford EL. Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation 2001, 72:726.
12. Slowinski T, Diehr P, Kleemann P. No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients. Nephrol Dial Transplant 2004, 19:2846.
13. Jeunemaitre X, Soubrier F, Kotelevtsev YV. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169.
14. Katsuya T, Koike G, Yee TW. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995, 345:1600.
15. Prasad GV, Pinnaduwage D, Parkes RK. Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction. Transplantation 2003, 75:209.
16. Bonnardeaux A, Davies E, Jeunemaitre X. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994, 24:63.
17. Van Geel PP, Pinto YM, Voors AA. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000, 35:717.
18. Fatini C, Abbate R, Pepe G. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J 2000, 21:633.
19. Nankivell BJ, Chapmann JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006, 81:643.
20. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993, 3:120.
21. Holmes CC, Adams BN. A probabilistic nearest neighbour method for statistical pattern recognition. J R Stat Soc Series B Stat Methodol 2002, 64:295.
22. Schweitzer EJ, Matas AJ, Gillingham KJ. Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 1991, 214:679.
23. Bassetel EA, Berthoux P, Cecillon S. Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1 R and ecNOS. Clin Nephrol 2002, 57:192.
24. Beige J, Offermann G, Distler A, Sharma AM. Angiotensin-converting-enzyme insertion/deletion genotype and long-term renal allograft survival. Nephrol Dial Transplant 1998, 13:735.
25. Beige J, Weber A, Engeli S, Offermann G, Distler A, Sharma AM. Angiotensinogen-M235T genotype and post-transplant hypertension. Nephrol Dial Transplant 1996, 11:1538.
26. Mondry A, Loh M, Liu P, Zhu A-L, Nagel M. Polymorphism of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrology 2005, 6:1.
27. Akcay A, Sezer S, Ozdemir FN. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation 2004, 78:892.
28. Matas AJ, Gillingham KJ, Humar A, Dunn DL, Sutherland DE, Najarian JS. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation 2000, 69:54.
29. Gjertson DW. Impact of delayed graft function and acute rejection on kidney graft survival. Clin Transplant 2000, 467.
30. Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999, 1:334.
31. Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ. Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant 2002, 16:425.
32. Reischig T, Jindra P, Svecova M, Kormunda S, Opatrny K, Treska V. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection. J Clin Virol 2006, 36:146.
33. Opelz G, Zeier M, Laux G, Morath C, Döhler B. No improvement of patient or graft survival in transplant recipients treated with ACEI or ARB. J Am Soc Nephrol 2006, 17:3257.
34. Yildiz A, Yazici H, Cine N. The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients. Clin Transplant 2002, 16:173.
35. Broekroelofs J, Stegeman CA, Navis G, Tegzess AM, De Zeeuw D, De Jong PE. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?. J Am Soc Nephrol 1998, 9:2075.
36. Luke RG. Pathophysiology and treatment of posttransplant hypertension. J Am Soc Nephrol 1991, 2:S37.
37. Barocci S, Ginevri F, Valente U, Torre F, Gusmano R, Nocera A. Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis. Transplantation 1999, 67:534.
38. Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993, 3:1531.